Sanofi considers listing consumer unit late next year Ruchika Sharma30 Oct 2023 2:30 PM ISTNew Delhi: Sanofi has mapped out a separate listing of its consumer healthcare business from the fourth quarter of next year, the French drugmaker...
GoodRx to offer Sanofi insulin injection Lantus for only USD 35 in US Ruchika Sharma24 Oct 2023 10:00 AM ISTUnited States: GoodRx has said it has collaborated with Sanofi to offer the drugmaker's most-prescribed insulin injection Lantus for only $35...
Require additional efficacy data for Dupixent approval for chronic spontaneous urticaria: USFDA to Sanofi Ruchika Sharma23 Oct 2023 4:44 PM ISTDupixent is a fully human monoclonal antibody that inhibits the signaling of the IL-4 and IL-13 pathways and is not an immunosuppressant.
Amlitelimab Phase 2b data show potential best-in-class profile in atopic dermatitis: Sanofi Ruchika Sharma16 Oct 2023 1:30 PM ISTParis: Sanofi has announced positive results from a Phase 2b study (STREAM-AD). The results showed that amlitelimab significantly improved signs...
Sanofi-Teva Pharma to co-develop, co-commercialize inflammatory bowel disease treatment Ruchika Sharma5 Oct 2023 2:30 PM ISTParis: Sanofi and Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. have announced a collaboration to co-develop and...
Sanofi, Janssen ink pact to develop vaccine for extraintestinal pathogenic E. coli Ruchika Sharma4 Oct 2023 5:30 PM ISTSanofi will pay USD 175M upfront to Janssen, followed by development and commercial milestones.
Sanofi Dupixent sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for USFDA priority review Ruchika Sharma28 Sept 2023 2:30 PM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...
Sanofi gets CDSCO panel nod to study atopic dermatitis drug Amlitelimab Dr. Divya Colin27 Sept 2023 6:00 PM ISTNew Delhi: The drug major Sanofi has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sanofi once-weekly Altuviiio approved in Japan for hemophilia A Ruchika Sharma25 Sept 2023 5:01 PM ISTParis: Sanofi has announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorization for ALTUVIIIO...
Health Bulletin 10/August/2023 Roshni Dhar10 Aug 2023 4:51 PM ISTHere are the top health stories for the day:Air we breath, and its deteriorating quality is associated with increased antibiotic resistanceCurbing...
Sanofi-AstraZeneca Beyfortus gets unanimous US CDC Advisory Committee recommendation to prevent RSV in neonates, infants Ruchika Sharma4 Aug 2023 1:09 PM ISTParis: Sanofi has recently announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization...
Sanofi to acquire Qunol Ruchika Sharma28 July 2023 1:30 PM ISTParis: Sanofi has announced it has entered into a definitive agreement to acquire ownership of Qunol, a U.S.-based brand in health & wellness....
